Cepheid, Inc. (NASDAQ: CPHD) announced the release of Xpert Norovirus, a qualitative in vitro diagnostic test for rapid identification and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE